エピソード

  • CRSP Today - Jul 17: Six-Day Slide Continues

    CRSP Today - Jul 17: Six-Day Slide Continues
    2026/07/17
    Hey there! I’m Joey, your friendly neighborhood investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a rough ride, closing down about half a percent. Yeah, it’s been a tough week.

    Now, here’s the scoop. CRISPR has been sliding for six straight days. That’s right, six! People are starting to wonder if it’s finally hit a cheap price, but honestly, it still feels like a slow bleed. Volume was way below average today, which means not a lot of folks were trading it. It’s like everyone’s holding their breath, waiting to see what happens next.

    So, why the drop? Well, a couple of articles pointed to some serious market pressure. It seems like investors are getting a little jittery about the biotech sector overall. Plus, some chatter around Intellia Therapeutics is stealing the spotlight. They’ve got some exciting stuff cooking in their pipeline, and it’s leaving CRISPR looking a bit overshadowed. Nobody really knows if this slide is just a temporary dip or something more serious.

    And speaking of the future, CRISPR’s got about $2.4 billion in cash on hand. So, they’re not exactly in a tight spot. That’s definitely something to keep in mind.

    To wrap it up, CRISPR’s been on a rough patch lately, and while some folks are wondering if it’s a good time to jump in, it’s still a wait-and-see game. Just remember, this is all for info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 16: Six Red Days in a Row

    CRSP Today - Jul 16: Six Red Days in a Row
    2026/07/16
    Hey there! It’s Joey here, your go-to guy for breaking down the stock scene. I’ve been in the investing game for years, and today we’re checking out CRISPR Therapeutics, or CRSP. Not a great day for them — the stock got smoked, down over 5%. Ouch.

    So, what happened? It’s been a rough stretch lately, and today marked six straight red days for CRSP. That’s a total drop of about 18% over this little losing streak. A lot of folks are feeling the pressure and hitting that sell button fast. Volume was pretty low today too, which usually means people are a bit hesitant to jump in right now.

    Now, why’s this happening? Well, the chatter around the stock is a mix of uncertainty and some folks questioning its fair value. There's a report floating around suggesting CRISPR has about $2.4 billion in cash, which sounds solid, but it hasn’t really helped the stock price. Investors are likely worried about the overall market and the competition heating up in the CRISPR space. Plus, there’s been some buzz about Intellia Therapeutics, which has a hefty short interest. That might be pulling some eyes away from CRISPR and causing a bit of a standoff in the market.

    And just to keep you in the loop, there’s talk about CRISPR needing to show some solid progress soon to win back investor confidence. They’ve got to prove they can deliver results to turn this ship around.

    So, yeah, it’s been a tough time for CRISPR. If you’re watching this stock, just keep your eyes peeled. Remember, this is just info and entertainment, not financial advice. Thanks for hanging out with me today! Catch you later!
    続きを読む 一部表示
    2 分
  • CRSP Today - Jul 15: Six Red Days in a Row

    CRSP Today - Jul 15: Six Red Days in a Row
    2026/07/15
    Hey there! It’s Joey here. I’ve been investing for a while now, and I’m breaking down the day for you. So, let’s talk about CRISPR Therapeutics, or CRSP for short. Today, it was a bit of a mixed bag, but overall, it was a red day—up just a little, but still down big over the past week.

    So, here’s what went down. CRSP barely moved today, just a small uptick of around three-quarters of a percent. But man, it’s been rough lately. This stock has been on a six-day losing streak. Yeah, you heard that right—six days! It’s dropped about 18% during that time. That’s gotta hurt. People are feeling pretty jittery about it.

    Now, what’s behind this downward trend? Well, it seems like a combo of things. There’s been a lot of chatter about the overall market and how it’s affecting biotech stocks, especially gene-editing companies like CRISPR. Investors are getting a bit cautious, and when that happens, they tend to hit the sell button fast. Plus, there hasn’t been any major news or breakthroughs from CRISPR lately to boost confidence. So, folks are left wondering what’s next.

    On a slightly brighter note, there’s been some movement in the background. Canal Insurance just bought a new stake in CRISPR. While it’s not a game-changer, it does show that some investors see potential here, even if the stock’s been struggling. It’s like a glimmer of hope amidst the storm.

    Overall, it’s been a tough time for CRISPR, but that’s how the market rolls sometimes. Just remember, investing can be a wild ride. Keep your head up, and don’t let the ups and downs get you down. This is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • CRSP Today - Jul 14: Market Reacts to New Stake

    CRSP Today - Jul 14: Market Reacts to New Stake
    2026/07/14
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for CRISPR Therapeutics, ticker CRSP. Today was a bit of a bummer—it finished in the red, down about 1.3%. Not exactly what we wanted to see.

    So, here’s the scoop. CRISPR started off okay, but then it kinda lost steam as the day went on. The volume was way lower than usual, so it felt like a slow day in the market. You know how sometimes stocks just seem to drift? Yeah, that was CRISPR today.

    Now, what’s behind this move? Well, there’s been some buzz about Canal Insurance picking up a new stake in CRISPR. On the surface, that sounds good, right? But it didn’t really light a fire under the stock. It’s like people were saying, “Cool, but what else ya got?” There was also some chatter about other gene-editing stocks being highlighted as top picks for 2026, and CRISPR just didn’t seem to be the star of the show today. The market can be funny like that—sometimes good news just isn’t enough to get folks excited.

    And here’s something to keep in mind: there’s been talk about a new “DNA shredder” technology that could change the game for gene-editing. It’s still early days, but if that really pans out, it could be a big deal for CRISPR. So, while today was a bit of a letdown, there’s potential on the horizon.

    Alright, that’s a wrap for today! Just remember, I’m here to give you the lowdown on what’s happening, not to tell you what to do with your cash. Stay curious, keep learning, and catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 13: Position Reduced by Trust Group

    CRSP Today - Jul 13: Position Reduced by Trust Group
    2026/07/13
    Hey, what’s up? It’s Joey here, your friendly neighborhood investor, breaking down the day for you. Today we’re talking about CRISPR Therapeutics, or CRSP for short. It was a red day, dropping about 3.3%. Ouch.

    So, what happened? CRISPR got smoked today, and a big part of that was news that Sumitomo Mitsui Trust Group decided to cut their position in the stock. When big players pull back, it tends to freak out other investors, and you know what happens next — people hit the sell button fast. That’s definitely a bummer for anyone holding shares.

    Now, why did this happen? Well, it seems like some investors are worried about the overall market conditions and how it might affect biotechs like CRISPR. There’s a lot of chatter about the sector right now, and not all of it’s positive. Some articles pointed out that while CRISPR has potential, the surrounding market vibes aren’t exactly uplifting. Plus, there are other biopharma companies making big moves, and that can make investors a bit antsy about where to put their cash.

    And here's a quick thing to keep in mind: there are still some folks out there saying CRISPR has a lot of promise. Like, some articles are even pointing out reasons to buy the stock, which is interesting given today’s drop. It’s one of those classic "love it or leave it" situations, I guess.

    So, yeah, today was a bit of a rough ride for CRISPR. But hey, that’s how the market goes sometimes. Just remember, this is all for your info and entertainment. I'm not here to tell you what to do with your money. Keep your head up, and happy investing!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 12: Stock Dips While Market Gains

    CRSP Today - Jul 12: Stock Dips While Market Gains
    2026/07/12
    Hey there! It’s Joey here, your friendly investor, breaking down what went down with CRISPR Therapeutics today. So, CRSP had a rough day, dropping about 5.3%. Ouch!

    Basically, it got smoked while the overall market was feeling pretty good. Not the best look, right? The stock opened lower and just kinda kept sliding throughout the day. People were definitely hitting the sell button fast, and it didn’t help that the trading volume was pretty high—over 2 million shares changed hands.

    Now, why did this happen? Well, a couple of things. First off, there was news that Sumitomo Mitsui Trust Group cut their position in CRSP. That’s usually a red flag for investors. When big players start pulling back, it can make everyone else nervous. Plus, there were a few articles floating around that pointed out some reasons to buy the stock, but they didn’t seem to sway the market today. It's like folks were just not feeling it, even with some positive chatter out there.

    And here’s a fun little tidbit: the biotech space is buzzing right now, with CRISPR having some solid potential down the line. There’s talk about over $2 billion in potential revenue for the company, which is definitely something to keep an eye on. But today, it was all about the dip.

    So, yeah, that one stung for CRISPR investors. It’s a tough gig watching a stock take a hit, especially when the rest of the market seems to be moving up. But hey, that’s how it goes sometimes in the stock game.

    Remember, this is just for info and entertainment, not financial advice. Stay chill, and I’ll catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 11: Stock Dips While Market Gains

    CRSP Today - Jul 11: Stock Dips While Market Gains
    2026/07/11
    Hey there! It’s Joey, your friendly neighborhood investor. Just breaking down the day for you. Today, we’re talking about CRISPR Therapeutics, and yeah, it was a rough one—CRSP dipped about 5.3%. Ouch!

    So, here’s the scoop. The stock got smoked today, closing down almost three bucks. It was a pretty active day with over two million shares traded. That’s way above the average, so you know there was a lot of action. But honestly, nobody really knows what kicked off the sell-off. The market was generally up, but CRISPR was going the other way. Classic case of a stock doing its own thing, right?

    Now, let’s chat about why this happened. A few articles popped up talking about CRISPR’s potential and some solid reasons to buy the stock, but it seems like those didn’t do much to lift spirits today. Instead, people were more focused on the dip, and some investors hit the sell button fast. There was also some buzz about other stocks like Viking Therapeutics, which might’ve pulled attention away from CRISPR. When people start comparing stocks, it can get a little dicey, especially when one is surging while another takes a hit.

    One thing to keep on your radar is that CRISPR’s got some interesting projects in the pipeline. They’re working on some gene-editing treatments that could be game-changers. So, while today was a bummer, the future might still hold some bright spots.

    Alright, that’s a wrap for today! Remember, I’m just here to share what’s happening, not to give any financial advice. Always do your own research, and keep it chill. Catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 10: Stock Gets Smoked

    CRSP Today - Jul 10: Stock Gets Smoked
    2026/07/10
    Hey there! It’s Joey here, your friendly investor buddy. Just breaking down the day for you. Today, we’re talking about CRISPR Therapeutics, and wow, it was a red day. The stock got smoked, down over six percent. Ouch.

    So, what happened? Well, the stock started off kinda shaky and just kept dropping throughout the day. It felt like a slow bleed, and people were definitely hitting that sell button fast. Not a good look, right?

    Now, why did it go down? No one really knows for sure, but there’s been a lot of chatter about CRISPR's competition lately. There’s this buzz about Viking Therapeutics, and they’re getting some attention for their weight loss treatments. A few articles were comparing the two, and it seems like investors might be feeling a bit nervous about CRISPR’s position in the market. Plus, with all the hype around NTLA surging recently, it looks like CRSP is kinda getting overshadowed. That one stung.

    One thing to keep an eye on is the ongoing discussions about advancements in gene editing. CRISPR's still in the game, and there are over two billion reasons to love what they're doing right now. That’s some serious cash flow potential if they play their cards right.

    So, yeah, it was a rough day for CRISPR. But hey, that’s how the market rolls sometimes. Just remember, this is all for informational purposes and a bit of fun. No financial advice here, just me chatting about the stock world. Catch you later!
    続きを読む 一部表示
    1 分